transferencia

[et_pb_section bb_built="1"][et_pb_row][et_pb_column type="4_4"][et_pb_text _builder_version="3.0.76" background_layout="light" border_style="solid"] [one_fourth] [/one_fourth] [three_fourth_last][box] CSIC has synthetized and studied unknown polyphenolic compounds possessing high antioxidant activity, comparable and in some cases even higher than those of known natural polyphenols, as resveratrol and hydroxytyrosol.[/box] Download Leaflet [/three_fourth_last] [/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]...

[one_fourth] [/one_fourth][three_fourth_last][box]The CSIC, Rey Juan Carlos University and the Hospital de Alcorcón carbonílicos have developed new derivatives of 1-indazolyl cannabinoid drugs as multitarget properties and / or cholinergic and / or regulators of beta-amyloid pétido. These compounds may serve for both for treatment and prevention of diseases and regulated by said systems, primarily for the treatment of Alzheimer's disease disorders.[/box] Download Leaflet [/three_fourth_last]...

[one_fourth] [/one_fourth][three_fourth_last][box]CSIC, CIBER and the University of Barcelona have found a family of derivatives heterocyclic compounds which act as activators of protein kinase AMPK. This enzyme regulates the energy state of the cell, so these compounds may be useful for the treatment of metabolic, cardiovascular disease and cancer, among others.[/box] Download Leaflet [/three_fourth_last]...

[et_pb_section bb_built="1"][et_pb_row][et_pb_column type="4_4"][et_pb_text _builder_version="3.0.83"] [one_fourth] [/one_fourth][three_fourth_last][box]UMH CSIC and have synthesized and studied a heterocyclic compounds capable of blocking activation thermoreceptors, particularly termosensoriales TRPM8 channels. Therefore, these compounds may be useful in treating diseases of the respiratory system, skin, eye, resulting from cancer chemotherapy and cancer.[/box] Download Leaflet [/three_fourth_last] [/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]...

[one_fourth] [/one_fourth] [three_fourth_last][box] CSIC and University of Toronto have found a new family of chromenopyrazole derivatives which act as modulators of the G-protein-coupled receptor 55 (GPR55). Therefore, these compounds are useful for the treatment of pathologies and disorders where GPR55 receptor is relevant, such as diabetes, cancer, inflammatory and neuropathic pain, bone diseases, Parkinson disease and multiple sclerosis. They might be also useful as pharmacological tools. Pharmaceutical companies interested in a patent licence are sought.[/box] Download Leaflet [/three_fourth_last] ...

[one_fourth] [/one_fourth][three_fourth_last][box]CSIC, CIBERNED and UAM have found a new family of phenylacetamide derivatives which act as modulators of the calcium neuronal sensor DREAM (Downstream Regulator Element Antagonist Modulator). Therefore, these compounds are useful for the treatment of pathologies associated to change in the DREAM activity, including neurodegenerative and autoinflammatory diseases, and sensory perception disorders.[/box] Download Leaflet [/three_fourth_last]...

PHP Code Snippets Powered By : XYZScripts.com